Ticker Details
Savara Inc. Savara Inc is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases.
IPO Date:	March 11, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.03B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.13 | 3.11%
Avg Daily Range (30 D):	$0.15 | 2.84%
Avg Daily Range (90 D):	$0.14 | 2.64%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	1.01M
Avg Daily Volume (90 D):	1.21M

Trade Size
Avg Trade Size (Sh.):	167
Avg Trade Size (Sh.) (30 D):	87
Avg Trade Size (Sh.) (90 D):	89

Institutional Trades
Total Institutional Trades:	619
Avg Institutional Trade:	$1.57M
Avg Institutional Trade (30 D):	$1.02M
Avg Institutional Trade (90 D):	$1.3M
Avg Institutional Trade Volume:	.35M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.74M
Avg Closing Trade (30 D):	$1.09M
Avg Closing Trade (90 D):	$1.32M
Avg Closing Volume:	376.5K

News

May 11, 2026 @ 8:05 PM Savara Announces Participation in the H.C. Wainwri... Source: Business Wire

Mar 6, 2026 @ 9:05 PM Savara Provides Regulatory Update on the MOLBREEVI... Source: Business Wire

Mar 4, 2026 @ 9:05 PM Savara Announces Participation in 2026 Citizens Li... Source: Business Wire

Feb 4, 2026 @ 9:05 PM Savara Announces Participation in Upcoming Investo... Source: Business Wire

Jan 24, 2026 @ 4:38 PM SAVARA INVESTIGATION ALERT: Bragar Eagel & Squire,... Source: Bragar Eagel & Squire, P.C.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.15	$-.13	$-.53
Diluted EPS	$-.15	$-.13	$-.53
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-37.28M	$-32.24M	$-118.84M
Operating Income / Loss	$-38.99M	$-33.42M	$-123.55M
Cost of Revenue
Net Cash Flow	$5.54M	$16.94M	$18.33M
PE Ratio

Splits
Apr 28, 2017	1:70
Apr 26, 2010	1:25
Jul 26, 2000	1:2